John L. Marshall, MD, chief, Division of Hematology and Oncology, Medstar Georgetown University Hospital, and director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers, discusses the safety profile of Yttrium-90 (Y-90), particularly when combined with capecitabine as a treatment for patients with liver-dominant metastatic colorectal cancer (mCRC).
Ещё видео!